These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 35595122)

  • 41. Utility of COVID-19 Screening in Cancer Patients.
    Lee LYW; Hill T; Topping O; Tilby M; Baker M; Greig J; Isherwood L; Miller R; Petrenko Y; Desai R; Field A; Kennedy B; Khan S; Kountourou A; Ndlovu S; Starkey T; Storey F; Turner L; Vaughan-Williams W; Moyler S; Preston H; Latty B; Walker S; Henderson DR; Thompson J; Jones N; Ghafoor Q; Pascoe J; Williams S; Middleton G;
    Cancer Cell; 2020 Sep; 38(3):306-307. PubMed ID: 32730750
    [No Abstract]   [Full Text] [Related]  

  • 42. Hospital mortality in patients with rare diseases during pandemics: lessons learnt from the COVID-19 and SARS pandemics.
    Chung CCY; Wong WHS; Chung BHY
    Orphanet J Rare Dis; 2021 Aug; 16(1):361. PubMed ID: 34384469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SARS-CoV-2 viremia may predict rapid deterioration of COVID-19 patients.
    Tan C; Li S; Liang Y; Chen M; Liu J
    Braz J Infect Dis; 2020; 24(6):565-569. PubMed ID: 32950458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The trinity of COVID-19: immunity, inflammation and intervention.
    Tay MZ; Poh CM; Rénia L; MacAry PA; Ng LFP
    Nat Rev Immunol; 2020 Jun; 20(6):363-374. PubMed ID: 32346093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Community Mitigation During SARS-CoV-2 Pandemic: Mission Impossible in Developing Countries.
    Abdel-Moneim AS
    Popul Health Manag; 2021 Feb; 24(1):6-7. PubMed ID: 32421383
    [No Abstract]   [Full Text] [Related]  

  • 46. Seropositivity and risk factors for SARS-CoV-2 infection in staff working in care homes during the COVID-19 pandemic.
    Rowland TAJ; Whitaker H; Jeffery-Smith A; Lang N; Sendall K; McLaren R; Brown KE; Ramsay M; Ladhani SN; Zambon M
    J Infect; 2021 Apr; 82(4):84-123. PubMed ID: 33160012
    [No Abstract]   [Full Text] [Related]  

  • 47. Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam.
    Chau NVV; Nhan LNT; Nguyet LA; Tu NTK; Hong NTT; Man DNH; Ty DTB; Nhu LNT; Yen LM; Khanh TH; Quy DT; Minh NNQ; Ny NTH; Anderson D; Wang LF; van Doorn HR; Hung NT; Thanh TT; Thwaites G; Tan LV;
    Int J Infect Dis; 2021 Oct; 111():127-129. PubMed ID: 34339862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autopsies and Asymptomatic Patients During the COVID-19 Pandemic: Balancing Risk and Reward.
    Nioi M; Napoli PE; Fossarello M; d'Aloja E
    Front Public Health; 2020; 8():595405. PubMed ID: 33240836
    [No Abstract]   [Full Text] [Related]  

  • 49. [COVID-toes, a cutaneous sign of innate resistance to SARS-CoV-2].
    Yatim A; Gilliet M
    Rev Med Suisse; 2021 Mar; 17(732):646-652. PubMed ID: 33793103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS-CoV-2 (COVID-19) and the lessons learned from global pandemic.
    Acquilla S; Sibal B; Shukla H; Mathews S; Rai GK; Lakhanpaul M
    Indian J Public Health; 2021; 65(3):215-217. PubMed ID: 34558480
    [No Abstract]   [Full Text] [Related]  

  • 51. COVID-19, SARS -CoV-2, Origin, Transmission and Treatment Aspects, A Brief Review.
    Nawaz S
    Infect Disord Drug Targets; 2021; 21(5):e270421186673. PubMed ID: 33023459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Role of public laboratories in the SARS-CoV-2 diagnosis in the COVID-19 pandemic: experience, challenges and opportunities. March 2021].
    Acevedo-Muñoz W; Benadof-Fuentes D; Farfán-Urzúa MJ
    Rev Chilena Infectol; 2021 Apr; 38(2):135-143. PubMed ID: 34184702
    [No Abstract]   [Full Text] [Related]  

  • 53. Crimes against humanity in Brazil's covid-19 response-a lesson to us all.
    Ventura D; Aith F; Reis R
    BMJ; 2021 Oct; 375():n2625. PubMed ID: 34706875
    [No Abstract]   [Full Text] [Related]  

  • 54. Influence of the SARS-CoV-2 pandemic: a review from the climate change perspective.
    Ukhurebor KE; Singh KR; Nayak V; Uk-Eghonghon G
    Environ Sci Process Impacts; 2021 Aug; 23(8):1060-1078. PubMed ID: 34132283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expert Opinions on the Current Therapeutic Management of Inflammatory Bowel Disease during the COVID-19 Pandemic: Japan IBD COVID-19 Taskforce, Intractable Diseases, the Health and Labor Sciences Research.
    Nakase H; Matsumoto T; Matsuura M; Iijima H; Matsuoka K; Ohmiya N; Ishihara S; Hirai F; Wagatsuma K; Yokoyama Y; Hisamatsu T
    Digestion; 2021; 102(5):814-822. PubMed ID: 32892197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Repeat laboratory testing of SARS-CoV-2 is necessary to diagnose COVID-19.
    Zhuang G; Ou X; Zhou L; Pan X; Li G
    J Infect Public Health; 2021 Sep; 14(9):1164-1168. PubMed ID: 34391172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detectable Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Human Breast Milk of a Mildly Symptomatic Patient With Coronavirus Disease 2019 (COVID-19).
    Tam PCK; Ly KM; Kernich ML; Spurrier N; Lawrence D; Gordon DL; Tucker EC
    Clin Infect Dis; 2021 Jan; 72(1):128-130. PubMed ID: 32472683
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COVID-19 and obesity: the meeting of two pandemics.
    Brandão SCS; Godoi ETAM; de Oliveira Cordeiro LH; Bezerra CS; de Oliveira Xavier Ramos J; de Arruda GFA; Lins EM
    Arch Endocrinol Metab; 2021 Nov; 65(1):3-13. PubMed ID: 33320454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The SARS-CoV-2 omicron wave is indicating the end of the pandemic phase but the COVID-19 will continue.
    Daria S; Islam MR
    J Med Virol; 2022 Jun; 94(6):2343-2345. PubMed ID: 35098543
    [No Abstract]   [Full Text] [Related]  

  • 60. Intersecting Pandemics of HIV and SARS-CoV-2: Commentary on the Special Issue.
    Vermund SH
    Curr HIV/AIDS Rep; 2022 Feb; 19(1):1-4. PubMed ID: 35192108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.